A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of differen... by Dierig, A, Hoelscher, M, Schultz, S, Hoffmann, L, Jarchow-MacDonald, A, Svensson, E M, Te Brake, L, Aarnoutse, R, Boeree, M, McHugh, T D, Wildner, L M, Gong, X, Phillips, Ppj, Minja, L T, Ntinginya, N, Mpagama, S, Liyoyo, A, Wallis, R S, Sebe, M, Mhimbira, F A, Mbeya, B, Rassool, M, Geiter, L, Cho, Y L, Heinrich, N

Get full text

Methodological considerations in clinical trials for new MDR-TB treatment regimens by Phillips, P. P. J.

Get full text

Treatment-shortening regimens for tuberculosis: updates and future priorities by Saluzzo, Francesca, Adepoju, Victor Abiola, Duarte, Raquel, Lange, Christoph, Phillips, Patrick P J

Get full text

Standards for clinical trials for treating TB by du Cros, P., Greig, J., Alffenaar, J.-W. C., Cross, G. B., Cousins, C., Berry, C., Khan, U., Phillips, P. P. J., Velásquez, G. E., Furin, J., Spigelman, M., Denholm, J. T., Thi, S. S., Tiberi, S., Huang, G. K. L., Marks, G. B., Turkova, A., Guglielmetti, L., Chew, K. L., Nguyen, H. T., Ong, C. W. M., Brigden, G., Singh, K. P., Motta, I., Lange, C., Seddon, J. A., Nyang'wa, B-T., Maug, A. K. J., Gler, M. T., Dooley, K. E., Quelapio, M., Tsogt, B., Menzies, D., Cox, V., Upton, C. M., Skrahina, A., McKenna, L., Horsburgh, C. R., Dheda, K., Marais, B. J.

Get full text